Dr. Shah: StatePharma to commence operations in July; six months needed for full stabilization

Dr. Shah Mahir, Managing Director of the newly established state-owned pharmaceutical company, StatePharma, stated on Tuesday that the company will officially assume its responsibilities on July 1, while stressing it will take approximately six months for the new pharmaceutical procurement and distribution system to fully stabilize.

Speaking at the Parliament’s Committee on State-Owned Enterprises, Dr. Shah explained that a six-month transition period is expected following the takeover to achieve full operational efficiency. He emphasized that the process will be implemented according to a structured and clearly defined timeline.

According to Dr. Shah, the additional time is necessary to complete several crucial tasks necessary to resolve existing challenges in the procurement of medicine as well as economic constraints. These include transferring STO pharmacies across the islands to StatePharma’s management, pre-ordering essential medicines, and establishing the institutional and operational framework required for nationwide distribution.

"Therefore, to harmonize all these elements and implement a long-term solution, I estimate it will take about six months from the takeover date," he stated.

He further underscored that the government’s objective extends beyond a temporary remedy, aiming instead to establish a sustainable and reliable system that ensures the continuous availability of essential medicines to the public.

StatePharma was established to facilitate the import of high-quality medicines at affordable prices and to ensure equitable access across the Maldives.

to visit multiple pharmacies to locate specific medications, as well as bearing significant out-of-pocket expenses for medications not covered under Aasandha. Concerns have also been raised regarding delays in sourcing medicines from abroad when they are unavailable domestically.